Response Biomedical (V.RBM) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Gold/Mining/Energy : Response Biomedical (V.RBM)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Dick Martin who wrote (536)	12/14/2004 10:06:27 AM
From: Starowl	of 655

I got the shareholder note, too. Radvak at least acknowledged the issue of dilution: "Although the Company is sensitive to shareholder concerns about dilution, additional proceeds have been periodically required for capital investment to automate and scale-up manufacturing capability, while strengthening the Company's balance sheet as we finalize partnership agreements. As a growth oriented company, these are necessary expenditures to meet near term demand and ensure significant long term commercial success." Dilution has been an issue with me for a long time. I understand capital is needed for growth and if we hadn't had a very remarkable year in terms of product approvals and various positive relationships, I would find it difficult tolerating the continued dilution. It's like printing money to pay debts. But the momemtum of growth and development is increasing and I believe it will continue.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next